<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>entacapone</title><link>http://www.unboundmedicine.com/medline/ebm/research/entacapone</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19909787/full_citation/Impaired_transmethylation_potential_in_Parkinson's_disease_patients_treated_with_L_Dopa_</link><description>Bonis ML, Tessitore A, Pellecchia MT, et al. <br/><span class="title">Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa. [JOURNAL ARTICLE]</span><br/><span class="source" title="Neuroscience letters">Neurosci Lett 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19909787/abstract/Impaired_transmethylation_potential_in_Parkinson's_disease_patients_treated_with_L_Dopa_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19909787/full_citation/Impaired_transmethylation_potential_in_Parkinson's_disease_patients_treated_with_L_Dopa_">Full Citation</a></description></item><item><title>Establishing the probable mechanism of L-DOPA in Alzheimer's disease management.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19894644/full_citation/Establishing_the_probable_mechanism_of_L_DOPA_in_Alzheimer's_disease_management_</link><description>Nivsarkar M, Banerjee A <br/><span class="title">Establishing the probable mechanism of L-DOPA in Alzheimer's disease management. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Acta poloniae pharmaceutica">Acta Pol Pharm 2009 Sep-Oct; 66(5):483-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19894644/abstract/Establishing_the_probable_mechanism_of_L_DOPA_in_Alzheimer's_disease_management_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19894644/full_citation/Establishing_the_probable_mechanism_of_L_DOPA_in_Alzheimer's_disease_management_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19894644/Establishing_the_probable_mechanism_of_L_DOPA_in_Alzheimer's_disease_management_">Find Related Articles</a> </description></item><item><title>Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879254/full_citation/Entacapone_a_catechol_O_methyltransferase_inhibitor_improves_the_motor_activity_and_dopamine_content_of_basal_ganglia_in_a_rat_model_of_Parkinson's_disease_induced_by_Japanese_encephalitis_virus_</link><description>Hamaue N, Ogata A, Terado M, et al. <br/><span class="title">Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus. [JOURNAL ARTICLE]</span><br/><span class="source" title="Brain research">Brain Res 2009 Oct 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879254/abstract/Entacapone_a_catechol_O_methyltransferase_inhibitor_improves_the_motor_activity_and_dopamine_content_of_basal_ganglia_in_a_rat_model_of_Parkinson's_disease_induced_by_Japanese_encephalitis_virus_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19879254/full_citation/Entacapone_a_catechol_O_methyltransferase_inhibitor_improves_the_motor_activity_and_dopamine_content_of_basal_ganglia_in_a_rat_model_of_Parkinson's_disease_induced_by_Japanese_encephalitis_virus_">Full Citation</a></description></item><item><title>Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson's disease: a case series.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19829918/full_citation/Levodopa/carbidopa/entacapone_200/50/200_mg__Stalevo_200__in_the_treatment_of_Parkinson's_disease:_a_case_series_</link><description>Sethi KD, Hauser RA, Isaacson SH, et al. <br/><span class="title">Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson's disease: a case series. [Journal Article]</span><br/><span class="source" title="Cases journal">Cases J 2009.:7134.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19829918/abstract/Levodopa/carbidopa/entacapone_200/50/200_mg__Stalevo_200__in_the_treatment_of_Parkinson's_disease:_a_case_series_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19829918/full_citation/Levodopa/carbidopa/entacapone_200/50/200_mg__Stalevo_200__in_the_treatment_of_Parkinson's_disease:_a_case_series_">Full Citation</a></description></item><item><title>Capture Compound Mass Spectrometry (CCMS) Sheds Light on the Molecular Mechanisms of Liver Toxicity of two Parkinson Drugs.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19783845/full_citation/Capture_Compound_Mass_Spectrometry__CCMS__Sheds_Light_on_the_Molecular_Mechanisms_of_Liver_Toxicity_of_two_Parkinson_Drugs_</link><description>Fischer JJ, Michaelis S, Schrey AK, et al. <br/><span class="title">Capture Compound Mass Spectrometry (CCMS) Sheds Light on the Molecular Mechanisms of Liver Toxicity of two Parkinson Drugs. [JOURNAL ARTICLE]</span><br/><span class="source" title="Toxicological sciences : an official journal of the Society of Toxicology">Toxicol Sci 2009 Sep 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19783845/abstract/Capture_Compound_Mass_Spectrometry__CCMS__Sheds_Light_on_the_Molecular_Mechanisms_of_Liver_Toxicity_of_two_Parkinson_Drugs_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19783845/full_citation/Capture_Compound_Mass_Spectrometry__CCMS__Sheds_Light_on_the_Molecular_Mechanisms_of_Liver_Toxicity_of_two_Parkinson_Drugs_">Full Citation</a></description></item><item><title>Shortness of breath, a 'wearing-off' symptom in Parkinson's disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19715385/full_citation/Shortness_of_breath_a_'wearing_off'_symptom_in_Parkinson's_disease_</link><description>Khan W, Naz S, Rana AQ <br/><span class="title">Shortness of breath, a 'wearing-off' symptom in Parkinson's disease. [Journal Article]</span><br/><span class="source" title="Clinical drug investigation">Clin Drug Investig 2009; 29(10):689-91.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19715385/abstract/Shortness_of_breath_a_'wearing_off'_symptom_in_Parkinson's_disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19715385/full_citation/Shortness_of_breath_a_'wearing_off'_symptom_in_Parkinson's_disease_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19715385/Shortness_of_breath_a_'wearing_off'_symptom_in_Parkinson's_disease_">Find Related Articles</a> </description></item><item><title>Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19704083/full_citation/Dopamine_agonists_in_6_pyruvoyl_tetrahydropterin_synthase_deficiency_</link><description>Porta F, Mussa A, Concolino D, et al. <br/><span class="title">Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. [Comparative Study, Journal Article]</span><br/><span class="source" title="Neurology">Neurology 2009 Aug 25; 73(8):633-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19704083/abstract/Dopamine_agonists_in_6_pyruvoyl_tetrahydropterin_synthase_deficiency_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19704083/full_citation/Dopamine_agonists_in_6_pyruvoyl_tetrahydropterin_synthase_deficiency_">Full Citation</a> | <a href="http://www.neurology.org/cgi/pmidlookup%3fview=long%26amp;pmid=19704083">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19704083/Dopamine_agonists_in_6_pyruvoyl_tetrahydropterin_synthase_deficiency_">Find Related Articles</a> </description></item><item><title>Peripheral COMT inhibition prevents levodopa associated homocysteine increase.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19657587/full_citation/Peripheral_COMT_inhibition_prevents_levodopa_associated_homocysteine_increase_</link><description>Müller T, Muhlack S <br/><span class="title">Peripheral COMT inhibition prevents levodopa associated homocysteine increase. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of neural transmission (Vienna, Austria : 1996)">J Neural Transm 2009 Aug 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19657587/abstract/Peripheral_COMT_inhibition_prevents_levodopa_associated_homocysteine_increase_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19657587/full_citation/Peripheral_COMT_inhibition_prevents_levodopa_associated_homocysteine_increase_">Full Citation</a></description></item><item><title>Simultaneous analysis of catechol-O-methyl transferase activity, S-adenosylhomocysteine and adenosine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19629963/full_citation/Simultaneous_analysis_of_catechol_O_methyl_transferase_activity_S_adenosylhomocysteine_and_adenosine_</link><description>Reenilä I, Rauhala P <br/><span class="title">Simultaneous analysis of catechol-O-methyl transferase activity, S-adenosylhomocysteine and adenosine. [JOURNAL ARTICLE]</span><br/><span class="source" title="Biomedical chromatography : BMC">Biomed Chromatogr 2009 Jul 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19629963/abstract/Simultaneous_analysis_of_catechol_O_methyl_transferase_activity_S_adenosylhomocysteine_and_adenosine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19629963/full_citation/Simultaneous_analysis_of_catechol_O_methyl_transferase_activity_S_adenosylhomocysteine_and_adenosine_">Full Citation</a></description></item><item><title>Levodopa/carbidopa/entacapone in Parkinson's disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19589043/full_citation/Levodopa/carbidopa/entacapone_in_Parkinson's_disease_</link><description>Seeberger LC, Hauser RA <br/><span class="title">Levodopa/carbidopa/entacapone in Parkinson's disease. [Journal Article]</span><br/><span class="source" title="Expert review of neurotherapeutics">Expert Rev Neurother 2009 Jul; 9(7):929-40.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19589043/abstract/Levodopa/carbidopa/entacapone_in_Parkinson's_disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19589043/full_citation/Levodopa/carbidopa/entacapone_in_Parkinson's_disease_">Full Citation</a></description></item></channel></rss>